Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with docetaxel: An NRG Oncology/Gynecologic Oncology Group study
Open Access
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 136 (2) , 323-327
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancerGynecologic Oncology, 2011
- Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840Annals of Oncology, 2011
- Persistent Mobility Disability After Neurotoxic ChemotherapyPhysical Therapy, 2010
- Risk of Chemotherapy-Induced Peripheral Neuropathy in Large Population-Based Cohorts of Elderly Patients With Breast, Ovarian, and Lung CancerAmerican Journal of Therapeutics, 2010
- Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatmentGynecologic Oncology, 2009
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroupJournal of Clinical Oncology, 2009
- Health-Related Quality of Life During and After Intraperitoneal Versus Intravenous Chemotherapy for Optimally Debulked Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian CarcinomaJNCI: Journal of the National Cancer Institute, 2004
- Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapyAnnals of Oncology, 2004
- Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5International Journal of Gynecological Cancer, 2003